BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11751523)

  • 1. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.
    Masuda M; Suzui M; Weinstein IB
    Clin Cancer Res; 2001 Dec; 7(12):4220-9. PubMed ID: 11751523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
    Masuda M; Suzui M; Lim JT; Weinstein IB
    Clin Cancer Res; 2003 Aug; 9(9):3486-91. PubMed ID: 12960141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
    Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
    Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1.
    Fu Y; Chen A
    Biochem Pharmacol; 2006 Jul; 72(2):227-38. PubMed ID: 16750517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
    Lim YC; Cha YY
    J Surg Oncol; 2011 Dec; 104(7):776-80. PubMed ID: 21725973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
    Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
    Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
    Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
    Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
    J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
    Kim CH; Moon SK
    Arch Biochem Biophys; 2005 Mar; 435(2):264-72. PubMed ID: 15708369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
    Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
    Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.
    Liu X; Zhang DY; Zhang W; Zhao X; Yuan C; Ye F
    Nutr Cancer; 2011; 63(3):466-75. PubMed ID: 21391127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.
    Dong Z; Ma W; Huang C; Yang CS
    Cancer Res; 1997 Oct; 57(19):4414-9. PubMed ID: 9331105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
    Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
    Shimizu M; Deguchi A; Joe AK; Mckoy JF; Moriwaki H; Weinstein IB
    J Exp Ther Oncol; 2005; 5(1):69-78. PubMed ID: 16416603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
    Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
    Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.
    Thomas SM; Bhola NE; Zhang Q; Contrucci SC; Wentzel AL; Freilino ML; Gooding WE; Siegfried JM; Chan DC; Grandis JR
    Cancer Res; 2006 Dec; 66(24):11831-9. PubMed ID: 17178880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
    J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.
    Ahmad N; Cheng P; Mukhtar H
    Biochem Biophys Res Commun; 2000 Aug; 275(2):328-34. PubMed ID: 10964666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.